[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$apiParty6fBuHLCPZ1LTYs42XHdVbjpSDOYYPYzyxeAGwSN5Tp8":3,"$apiPartyCLp_EnDhsSvscfsoEaU5o2XwuoIu_YrzW6OPPgYAB5M":563,"$apiPartyCLp_EnDhsSvscfsoEaU5o2XwuoIu_YrzW6OPPgYAB5M$H93EERW16b":563},{"product_data":4,"scene_data":21,"task_data":407,"modality_data":441,"domain_data":478},[5,9,12,15,18],{"name":6,"value":7,"add_value":8,"describe":8},"Rivo","1","",{"name":10,"value":11,"add_value":8,"describe":8},"Cubo","2",{"name":13,"value":14,"add_value":8,"describe":8},"Moye","3",{"name":16,"value":17,"add_value":8,"describe":8},"Juro","4",{"name":19,"value":20,"add_value":8,"describe":8},"Ordo","5",[22,73,135,197,232,267,302,337,372],{"name":23,"value":7,"add_value":24,"describe":25,"children":26},"Home & Indoor","sofa","AI enhances everyday home life. Our datasets cover real indoor scenes to support smart devices, robotics, and home intelligence.",[27,29,31,33,35,37,40,43,46,49,52,55,58,61,64,67,70],{"name":28,"value":7},"Living Room",{"name":30,"value":11},"Bedroom",{"name":32,"value":14},"Kitchen",{"name":34,"value":17},"Dining Area",{"name":36,"value":20},"Bathroom",{"name":38,"value":39},"Entrance \u002F Foyer","6",{"name":41,"value":42},"Corridor \u002F Hallway","7",{"name":44,"value":45},"Staircase","8",{"name":47,"value":48},"Home Office","9",{"name":50,"value":51},"Hobby \u002F Game Room","10",{"name":53,"value":54},"Worship Space","11",{"name":56,"value":57},"Garage","12",{"name":59,"value":60},"Utility \u002F Laundry Room","13",{"name":62,"value":63},"Pantry","14",{"name":65,"value":66},"Basement","15",{"name":68,"value":69},"Garden","16",{"name":71,"value":72},"Balcony","17",{"name":74,"value":11,"add_value":75,"describe":76,"children":77},"Office & Educational","workshop","AI is reshaping work and learning. Our datasets capture offices and classrooms to power automation and next-generation productivity tools.",[78,81,84,87,90,93,96,99,102,105,108,111,114,117,120,123,126,129,132],{"name":79,"value":80},"Open Office","18",{"name":82,"value":83},"Private Office","19",{"name":85,"value":86},"Co-working Space","20",{"name":88,"value":89},"Reception \u002F Lobby","21",{"name":91,"value":92},"Conference Room","22",{"name":94,"value":95},"Huddle Room \u002F Booth","23",{"name":97,"value":98},"Lecture Hall \u002F Auditorium","24",{"name":100,"value":101},"Classroom","25",{"name":103,"value":104},"Science Laboratory","26",{"name":106,"value":107},"Library","27",{"name":109,"value":110},"Design Studio","28",{"name":112,"value":113},"Pantry \u002F Breakroom","29",{"name":115,"value":116},"Cafeteria \u002F Canteen","30",{"name":118,"value":119},"Restroom (Commercial)","31",{"name":121,"value":122},"Gymnasium \u002F Sports Hall","32",{"name":124,"value":125},"Server Room","33",{"name":127,"value":128},"Mailroom \u002F Logistics","34",{"name":130,"value":131},"Janitorial Closet","35",{"name":133,"value":134},"Corridor \u002F Elevators","36",{"name":136,"value":14,"add_value":137,"describe":138,"children":139},"Healthcare & Medical","love-and-help","AI is advancing modern healthcare. Our datasets include clinics and hospitals to enable clinical insights and medical automation.",[140,143,146,149,152,155,158,161,164,167,170,173,176,179,182,185,188,191,194],{"name":141,"value":142},"Operating Theatre \u002F OR","37",{"name":144,"value":145},"Consultation Room","38",{"name":147,"value":148},"Treatment Room","39",{"name":150,"value":151},"Dental Clinic","40",{"name":153,"value":154},"Inpatient Ward","41",{"name":156,"value":157},"Nurse Station","42",{"name":159,"value":160},"ICU","43",{"name":162,"value":163},"NICU (Neonatal ICU)","44",{"name":165,"value":166},"Emergency Room (ER)","45",{"name":168,"value":169},"Hospital Corridor","46",{"name":171,"value":172},"Waiting Area","47",{"name":174,"value":175},"CT\u002FMRI","48",{"name":177,"value":178},"Medical Laboratory","49",{"name":180,"value":181},"Phlebotomy Room","50",{"name":183,"value":184},"Rehabilitation Gym","51",{"name":186,"value":187},"Assisted Living Room","52",{"name":189,"value":190},"Pharmacy","53",{"name":192,"value":193},"Sterile Processing Dept","54",{"name":195,"value":196},"Medical Storage","55",{"name":198,"value":17,"add_value":199,"describe":200,"children":201},"Business & Public Service","business","AI is elevating commercial and public services. Our datasets span retail, dining, and service centers to improve intelligent operations.",[202,205,208,211,214,217,220,223,226,229],{"name":203,"value":204},"Shopping Mall Atrium","86",{"name":206,"value":207},"Supermarket Shelf","87",{"name":209,"value":210},"Self-Checkout Counter","88",{"name":212,"value":213},"Restaurant Dining Hall","89",{"name":215,"value":216},"Commercial Kitchen","90",{"name":218,"value":219},"Hotel Lobby","91",{"name":221,"value":222},"Subway Platform","92",{"name":224,"value":225},"Security Checkpoint","93",{"name":227,"value":228},"Underground Parking","94",{"name":230,"value":231},"Bank Teller Zone","95",{"name":233,"value":20,"add_value":234,"describe":235,"children":236},"Industrial & Manufacturing","robot-arm","AI is modernizing industry. Our datasets capture factories and logistics spaces to support robotics and intelligent manufacturing.",[237,240,243,246,249,252,255,258,261,264],{"name":238,"value":239},"Final Assembly Line","96",{"name":241,"value":242},"Quality Control Station","97",{"name":244,"value":245},"Robotic Welding Cell","98",{"name":247,"value":248},"CNC Machining Center","99",{"name":250,"value":251},"Cleanroom","100",{"name":253,"value":254},"Automated Warehouse","101",{"name":256,"value":257},"Loading Dock","102",{"name":259,"value":260},"Sorting Center","103",{"name":262,"value":263},"Chemical Plant","104",{"name":265,"value":266},"Power Substation","105",{"name":268,"value":39,"add_value":269,"describe":270,"children":271},"Transportation & Driving","car","AI is revolutionizing mobility. Our datasets capture road networks, vehicle dynamics and traffic scenarios to support autonomous driving and intelligent transportation systems.",[272,275,278,281,284,287,290,293,296,299],{"name":273,"value":274},"Urban Intersection","56",{"name":276,"value":277},"Highway \u002F Expressway","57",{"name":279,"value":280},"Tunnel","58",{"name":282,"value":283},"Roundabout","59",{"name":285,"value":286},"School \u002F Hospital Zone","60",{"name":288,"value":289},"Toll Station","61",{"name":291,"value":292},"Construction Zone","62",{"name":294,"value":295},"Parking Garage","63",{"name":297,"value":298},"Driver Cabin","64",{"name":300,"value":301},"Adverse Weather","65",{"name":303,"value":42,"add_value":304,"describe":305,"children":306},"Outdoor & Construction","tent-tree","AI is optimizing outdoor operations. Our datasets capture construction sites, open-air work zones and outdoor infrastructure to support smart construction and autonomous outdoor machinery.",[307,310,313,316,319,322,325,328,331,334],{"name":308,"value":309},"Excavation Site","66",{"name":311,"value":312},"Scaffolding Area","67",{"name":314,"value":315},"Material Storage Yard","68",{"name":317,"value":318},"Site Entrance","69",{"name":320,"value":321},"Roadwork Zone","70",{"name":323,"value":324},"Bridge Infrastructure","71",{"name":326,"value":327},"Transmission Line","72",{"name":329,"value":330},"Open-pit Mine","73",{"name":332,"value":333},"Tunneling Site","74",{"name":335,"value":336},"Post-Disaster Rubble","75",{"name":338,"value":45,"add_value":339,"describe":340,"children":341},"Nature, Aerial & Aquatic","global-loop","AI is exploring the natural world. Our datasets capture terrestrial landscapes, aerial vistas and aquatic ecosystems to support environmental monitoring and autonomous exploration systems.",[342,345,348,351,354,357,360,363,366,369],{"name":343,"value":344},"Deep Forest","76",{"name":346,"value":347},"Farmland \u002F Crops","77",{"name":349,"value":350},"River \u002F Lake","78",{"name":352,"value":353},"Open Ocean","79",{"name":355,"value":356},"Underwater Coral Reef","80",{"name":358,"value":359},"Fish Farm","81",{"name":361,"value":362},"Mountain Terrain","82",{"name":364,"value":365},"Urban Low Altitude","83",{"name":367,"value":368},"Fire Scene","84",{"name":370,"value":371},"Desert \u002F Gobi","85",{"name":373,"value":48,"add_value":374,"describe":375,"children":376},"Virtul & Digital","siri","AI is reshaping the virtual realm. Our datasets capture digital twins, virtual environments and simulated spaces to support metaverse development and intelligent digital interaction.",[377,380,383,386,389,392,395,398,401,404],{"name":378,"value":379},"VR Social Space","106",{"name":381,"value":382},"Synthetic Driving Sim","107",{"name":384,"value":385},"Digital Twin City","108",{"name":387,"value":388},"FPS \u002F MOBA Game","109",{"name":390,"value":391},"Robotics Gym","110",{"name":393,"value":394},"AR Navigation","111",{"name":396,"value":397},"Virtual Showroom","112",{"name":399,"value":400},"Code \u002F IDE Interface","113",{"name":402,"value":403},"App GUI Screen","114",{"name":405,"value":406},"Synthetic Face\u002FID","115",[408,411,414,417,420,423,426,429,432,435,438],{"name":409,"value":7,"add_value":410,"describe":8},"Classification","rubric",{"name":412,"value":11,"add_value":413,"describe":8},"Detection","radar",{"name":415,"value":14,"add_value":416,"describe":8},"Segmentation","segmentation",{"name":418,"value":17,"add_value":419,"describe":8},"Tacking","crosshairs",{"name":421,"value":20,"add_value":422,"describe":8},"Estimation","streamline",{"name":424,"value":39,"add_value":425,"describe":8},"QA","qa",{"name":427,"value":42,"add_value":428,"describe":8},"Recognition","finger-scan",{"name":430,"value":45,"add_value":431,"describe":8},"Control","control",{"name":433,"value":48,"add_value":434,"describe":8},"Extraction","extraction",{"name":436,"value":51,"add_value":437,"describe":8},"Retrieval","retrieval",{"name":439,"value":54,"add_value":440,"describe":8},"Forecast","forecast",[442,445,448,451,454,457,460,463,466,469,472,475],{"name":443,"value":7,"add_value":444,"describe":8},"Audio","audio",{"name":446,"value":11,"add_value":447,"describe":8},"Image","image",{"name":449,"value":14,"add_value":450,"describe":8},"Text","text",{"name":452,"value":17,"add_value":453,"describe":8},"Video","video",{"name":455,"value":20,"add_value":456,"describe":8},"Multi","multi",{"name":458,"value":39,"add_value":459,"describe":8},"Document","document",{"name":461,"value":42,"add_value":462,"describe":8},"Time-Series","time-series",{"name":464,"value":45,"add_value":465,"describe":8},"3D cloud","cloud",{"name":467,"value":48,"add_value":468,"describe":8},"Code","code",{"name":470,"value":51,"add_value":471,"describe":8},"Event","event",{"name":473,"value":54,"add_value":474,"describe":8},"Motion","motion",{"name":476,"value":57,"add_value":477,"describe":8},"Interaction","interaction",[479,482,487,491,494,499,504,509,514,519,524,528,532,536,540,544,548,552,556,559],{"id":480,"value":480,"name":233,"intro":481,"add_value":234,"describe":481},2,"智能质检：利用图像识别、多模态模型对产品外观或声音、振动等数据进行分析，自动识别缺陷，提高质量控制效率。\n工业知识问答与文档理解：通过大模型理解和总结技术文档、操作手册，实现快速问答、知识检索和培训支持。\n安全监测与风险预警：实时分析视频、传感器和操作日志，识别潜在危险行为或异常状态，提前预警，保障人员和设备安全。",{"id":483,"value":483,"name":484,"intro":485,"add_value":486,"describe":485},3,"Finance & Insurance","风险评估与预测：分析大量客户数据，评估信用风险、市场风险等，预测违约概率、股价走势等，辅助金融机构决策。\n智能投顾：根据客户风险偏好、资产状况等，提供个性化投资组合建议，实时调整投资策略。\n反欺诈检测：通过分析交易数据、用户行为，识别异常交易和欺诈行为，保障金融安全。","funds",{"id":488,"value":488,"name":489,"intro":490,"add_value":269,"describe":490},1,"Transport & Automotive","智能座舱：打造多模态交互的 AI 座舱，通过语音、手势、面部识别等实现人机交互，如语音控制导航、音乐播放。\n驾驶员状态监测：识别疲劳、分心、抽烟、打电话等行为，通过大模型判断危险等级，触发相应提醒或干预机制。\n智能驾驶：AI 用于环境感知、路径规划与决策控制，使车辆能识别道路、行人、障碍物等，实现自适应巡航、自动泊车、车道保持等功能，提升驾驶安全性与便利性。",{"id":492,"value":492,"name":136,"intro":493,"add_value":137,"describe":493},4,"医学影像诊断：分析 CT、MRI 等影像，辅助医生检测疾病、识别病灶，如 AI 系统可快速发现肺部结节。\n医患对话助手：通过自然语言处理理解患者问题，提供初步健康建议或就诊指导，缓解医生接诊压力。\n智能健康管理：根据用户健康数据，提供个性化健康建议、疾病预警，如智能手环结合 AI 分析用户运动、睡眠、心率等数据。",{"id":495,"value":495,"name":496,"intro":497,"add_value":498,"describe":497},6,"Smart Devices","多模态交互：支持语音、手势、眼神等多种交互方式，如 AI 眼镜可通过语音指令实现翻译、搜索功能。\n智能感知与处理：使设备能感知环境、理解用户需求，如智能音箱根据环境噪音自动调节音量。\n个性化服务：根据用户使用习惯和偏好，提供个性化功能与服务，如智能手表为用户定制运动健身计划。","microscope",{"id":500,"value":500,"name":501,"intro":502,"add_value":503,"describe":502},8,"Law & Government","智能法律问答：面向公众或企业用户，提供合规、劳动法、婚姻继承、知识产权等常见法律问题的智能解答。\n合同审查与风险识别：利用大模型分析合同内容，识别潜在风险条款、漏洞或不合理约定，提升合同审核质量。\n法律知识图谱构建：自动梳理法规、案例、条文之间的引用关系，构建语义化知识图谱，支持智能分析和推理。","hammer",{"id":505,"value":505,"name":506,"intro":507,"add_value":508,"describe":507},7,"Education & Training","个性化学习：根据学生学习进度、能力和知识掌握情况，推送个性化学习内容与练习，如智能辅导系统为学生制定专属学习计划。\n智能教学辅助：AI 助教协助教师进行作业批改、答疑解惑，还可分析教学数据，为教师提供教学反馈，优化教学方法。\n虚拟学习环境：利用 AI 创建虚拟实验、历史场景等，让学生沉浸式学习，如在虚拟化学实验室中进行实验操作。","degree-hat",{"id":510,"value":510,"name":511,"intro":512,"add_value":513,"describe":512},5,"Agriculture & Food","作物病虫害识别与防治：通过图像识别分析农作物叶片、果实等症状，识别病虫害类型，给出防治建议，减少产量损失。\n农产品质量检测：利用图像和传感器数据，识别果蔬等农产品的成熟度、外观缺陷，进行自动分级，提高市场竞争力。\n农情监测与预测：利用卫星遥感、气象和传感器数据，结合大模型预测作物长势、干旱、洪涝等农情变化。","ph-farm",{"id":515,"value":515,"name":516,"intro":517,"add_value":518,"describe":517},9,"Retail & E-commerce","智能客服：通过自然语言对话理解用户需求，提供产品推荐、订单查询、退换货支持等服务，提升客户满意度。\n个性化营销推荐：基于用户浏览、购买、偏好等行为数据，生成个性化推荐内容与优惠策略，提高转化率和客单价。\n商品内容生成：自动撰写商品标题、卖点描述、使用说明等内容，适用于海量SKU的内容生产与多语言发布。","buy",{"id":520,"value":520,"name":521,"intro":522,"add_value":523,"describe":8},10,"Security & Protection",null,"safe-shield-line",{"id":525,"value":525,"name":526,"intro":522,"add_value":527,"describe":8},11,"Environment & Climate","weather",{"id":529,"value":529,"name":530,"intro":522,"add_value":531,"describe":8},12,"Energy & Resource","energy-leaf",{"id":533,"value":533,"name":534,"intro":522,"add_value":535,"describe":8},13,"Express & Logistics","speed-outline",{"id":537,"value":537,"name":538,"intro":522,"add_value":539,"describe":8},15,"Sports","baseball-outline",{"id":541,"value":541,"name":542,"intro":522,"add_value":543,"describe":8},16,"General Data","daily-booth",{"id":545,"value":545,"name":546,"intro":522,"add_value":547,"describe":8},17,"Content & Media","media",{"id":549,"value":549,"name":550,"intro":522,"add_value":551,"describe":8},18,"Construction","construction",{"id":553,"value":553,"name":554,"intro":522,"add_value":555,"describe":8},19,"IT & Telecom","tech",{"id":557,"value":557,"name":558,"intro":522,"add_value":498,"describe":8},20,"Science & Research",{"id":560,"value":560,"name":561,"intro":522,"add_value":562,"describe":8},21,"Language & Culture","lang",{"id":564,"unique_code":565,"title":566,"icon":8,"intro":567,"cate":483,"detail":568,"create_time":569,"update_time":570,"price":571,"view_count":549,"download_count":572,"unit":572,"amount":573,"is_create_order":572,"enterprise_id":488,"seo_keywords":574,"seo_description":575,"data_format":576,"file_size":577,"apply_scene":578,"training_task":579,"version":580,"dataset_type_id":492,"dataset_scene_id":492,"sample_file":581,"banner":8,"unit_name":8,"cate_name":449,"icon_url":8,"banner_url":8,"sample_file_url":8,"data_dict":582,"qa_list":609,"sample_metadatas":626,"text_sample_content":657,"enterprise_name":658,"enterprise_logo":659,"data_distribution":660},1194,"d0116e86e9b6718fc3cbf951d28237a4","Health and Wellness Advertising Evidence Linkage Dataset","Train models to determine whether health and wellness advertising claims are genuinely supported by their cited evidence, including cases of weak support and overgeneralization.","\u003Cp>This dataset contains synthetic social media advertising claims about health, nutrition, and wellness, alongside related citations, research or product descriptions, and evidence excerpts. It covers key dimensions such as effect strength, target populations, study conditions, and overgeneralization. Structured annotations connect claims with evidence and assess the degree of support, making the dataset suitable for training and evaluating citation verification, health claim fact-checking, and evidence-grounding capabilities.\u003C\u002Fp>","2026-10-14 10:37:03","2026-10-19 17:18:41","0.00",0,5000,"health advertising dataset,wellness product ad review,health claim verification,citation verification data,evidence linkage dataset,nutrition ad review,fact checking training,synthetic text data","Synthetic health and wellness ad claims linked to citations and evidence, covering target populations, study conditions, and overgeneralization for verification","JSON","0.3GB","health and wellness advertising compliance, advertising claim verification, health marketing evidence assessment","evidence linkage, claim support verification, overgeneralization detection","V1.0","rivo\u002Fsample-packages\u002F256b6bad-60e1-4484-a537-f870c38ceec6\u002F20261014.zip",[583,588,594,599,604],{"id":572,"name":584,"field":585,"intro":586,"type":587},"File Name","file_name","File name","string",{"id":589,"name":590,"field":591,"intro":592,"type":593},8633,"Raw Advertising and Evidence Materials","raw_material","Unprocessed advertising claims, citation text, evidence excerpts, and research or product description context.","object",{"id":595,"name":596,"field":597,"intro":598,"type":593},8634,"Advertising Claim Analysis","claim_annotation","Structured information derived from advertising claims, including claim type, effects, target populations, and conditions.",{"id":600,"name":601,"field":602,"intro":603,"type":593},8635,"Claim-Evidence Support Judgment","support_judgment","An assessment of the actual support relationship, dimension alignment, and risk of overgeneralization based on comparison of the advertising claim and cited evidence.",{"id":605,"name":606,"field":607,"intro":608,"type":593},8636,"Evidence Content Analysis","evidence_annotation","Information derived from citations and evidence excerpts, including study type, evidence subject, effects, and study conditions.",[610,614,618,622],{"id":611,"question":612,"answer":613},6227,"What does the dataset contain?","It contains synthetic advertising claims about health, nutrition, and wellness, along with citation text, evidence excerpts, and research or product description context. Structured annotations cover claim analysis, evidence analysis, and judgments about the support relationship.",{"id":615,"question":616,"answer":617},6228,"Which evidence assessment dimensions are annotated?","Annotations cover claim type, effect strength, target population, and conditions, as well as evidence type, subject, effects, and study conditions. Support judgments also assess how well these dimensions align and whether the claim overgeneralizes the evidence.",{"id":619,"question":620,"answer":621},6229,"Which training and evaluation tasks does it support?","The dataset can support citation verification, claim-evidence matching, health-related fact checking, and overgeneralization detection. It can also help evaluate whether a model distinguishes conclusions supported by evidence from broader inferences made in advertising.",{"id":623,"question":624,"answer":625},6230,"How can the dataset be accessed, and what are the licensing terms?","Please refer to the dataset listing or accompanying license for access methods, permitted uses, and licensing terms. The data consists of synthetic text; suitability and compliance should still be assessed in light of the intended use and applicable policies.",[627,639,648],{"id":628,"relate_table":629,"relate_id":630,"file_size":572,"file_name":631,"path":8,"duration":572,"cate":483,"file_format":632,"audio_rate":8,"audio_channel":522,"audio_bit_depth":522,"quality":8,"annotation":633,"cate_name":634,"raw_material":635,"claim_annotation":636,"support_judgment":637,"evidence_annotation":638},14982,"union_cubo",2089439548,"样例_3.json","json","{\"raw_material\": \"{\\\"ad_claim_text\\\": \\\"Drinking three cups of black coffee per day can reduce the risk of type 2 diabetes in adults by 30%.\\\", \\\"citation_text\\\": \\\"A prospective cohort study followed adults without diabetes and compared the relationship between different coffee intake levels and subsequent development of type 2 diabetes.\\\", \\\"evidence_excerpt\\\": \\\"The study included 12,000 adults aged 30 to 65 without diabetes at baseline and followed them for 10 years. Compared with those who drank less than 1 cup per day, self-reported drinkers of 3 or more cups of coffee per day had an adjusted hazard ratio of 0.70 for developing type 2 diabetes. The study had an observational design, and the authors noted that residual confounding by diet, physical activity, and socioeconomic factors could not be completely ruled out.\\\", \\\"source_context\\\": {\\\"source_type\\\": \\\"Prospective observational study\\\", \\\"source_title_or_product_name\\\": \\\"Cohort study of coffee intake and risk of incident type 2 diabetes\\\", \\\"publication_year_or_version\\\": \\\", 2024\\\", \\\"study_design\\\": \\\"Prospective cohort study; groups were based on self-reported coffee intake at baseline, followed for 10 years, and adjusted hazard ratios were used to compare the risk of incident type 2 diabetes.\\\", \\\"population_description\\\": \\\"12,000 adults aged 30 to 65 without diabetes at baseline; the study population did not include children, older adults, or those with diabetes at baseline.\\\", \\\"intervention_description\\\": \\\"Observed participants' usual black coffee intake; the high-intake group self-reported drinking 3 or more cups per day, and coffee drinking was not randomly assigned.\\\", \\\"outcome_description\\\": \\\"Incident type 2 diabetes during follow-up, determined from medical records and study follow-up reports.\\\", \\\"study_conditions\\\": \\\"10-year observation period; coffee intake was mainly self-reported at baseline, and coffee type, cup size, brewing method, added sugar or milk, and other lifestyle factors were not strictly controlled.\\\"}}\", \"claim_annotation\": \"{\\\"claim_category\\\": \\\"Disease risk\\\", \\\"claim_target\\\": \\\"Black coffee\\\", \\\"claimed_effect\\\": \\\"Reduces the risk of developing type 2 diabetes in adults by 30%\\\", \\\"claimed_effect_direction\\\": \\\"Lowers or reduces\\\", \\\"claimed_effect_strength\\\": \\\"Significant effect\\\", \\\"claimed_population\\\": \\\"Adults\\\", \\\"claimed_outcome\\\": \\\"Risk of developing type 2 diabetes\\\", \\\"claim_conditions\\\": \\\"Drinking three cups of black coffee per day; duration, cup size standards, or other lifestyle conditions not specified.\\\"}\", \"support_judgment\": \"{\\\"relation_label\\\": \\\"Partially supported\\\", \\\"support_level\\\": \\\"Medium\\\", \\\"dimension_assessment\\\": {\\\"effect_direction_match\\\": \\\"Complete match\\\", \\\"effect_strength_match\\\": \\\"Partial match\\\", \\\"population_match\\\": \\\"Partial match\\\", \\\"outcome_match\\\": \\\"Complete match\\\", \\\"condition_match\\\": \\\"Partial match\\\", \\\"evidence_design_relevance\\\": \\\"Partially relevant\\\"}, \\\"extrapolation_flags\\\": [\\\"Expanding the applicable population\\\", \\\"Ignoring study conditions\\\", \\\"Inferring causality from correlation\\\"], \\\"unsupported_claim_aspects\\\": [\\\"Has the same effect in all adults\\\", \\\"Drinking three cups of black coffee per day can causally reduce risk by 30%\\\", \\\"Effects are consistent across different coffee cup sizes, brewing methods, and lifestyles\\\"], \\\"is_overgeneralized\\\": true, \\\"support_score\\\": 0.48, \\\"confidence\\\": 0.92, \\\"reasoning\\\": \\\"The prospective cohort study reported an association between higher coffee intake and lower risk of incident type 2 diabetes; the outcome measure and direction are consistent with the advertisement, and the hazard ratio was about 0.70. However, the study did not randomly assign coffee intake, coffee amount was self-reported, and the population was limited to those aged 30 to 65 without diabetes at baseline; residual confounding cannot be ruled out. Therefore, the evidence only partially supports an association and cannot prove that drinking three cups of black coffee per day has a certain 30% causal risk reduction effect in all adults.\\\"}\", \"evidence_annotation\": \"{\\\"evidence_type\\\": \\\"Observational study\\\", \\\"evidence_population\\\": \\\"Adults aged 30 to 65 without diabetes at baseline, totaling 12,000 people.\\\", \\\"evidence_intervention\\\": \\\"Observed self-reported coffee intake; the high-intake group drank 3 or more cups per day; no randomized intervention was performed.\\\", \\\"evidence_outcome\\\": \\\"Incident type 2 diabetes during 10-year follow-up; the high-intake group had an adjusted hazard ratio of 0.70 relative to those drinking less than 1 cup per day.\\\", \\\"evidence_effect_direction\\\": \\\"Higher coffee intake was associated with a lower risk of incident type 2 diabetes.\\\", \\\"evidence_effect_strength\\\": \\\"An approximately 30% relative risk difference was observed, but this is an adjusted association estimate, and the causal effect size is uncertain.\\\", \\\"evidence_conditions\\\": \\\"Observed for 10 years; intake was mainly self-reported at baseline; cup size, brewing method, additives, diet, exercise, and other confounding factors were not strictly controlled.\\\", \\\"evidence_scope_summary\\\": \\\"The study supports an association between higher coffee intake and lower disease risk in a specific age group without diabetes at baseline, but it cannot by itself prove that drinking three cups of black coffee per day causally reduces risk by 30% in all adults.\\\"}\"}","文本","{\"ad_claim_text\": \"Drinking three cups of black coffee per day can reduce the risk of type 2 diabetes in adults by 30%.\", \"citation_text\": \"A prospective cohort study followed adults without diabetes and compared the relationship between different coffee intake levels and subsequent development of type 2 diabetes.\", \"evidence_excerpt\": \"The study included 12,000 adults aged 30 to 65 without diabetes at baseline and followed them for 10 years. Compared with those who drank less than 1 cup per day, self-reported drinkers of 3 or more cups of coffee per day had an adjusted hazard ratio of 0.70 for developing type 2 diabetes. The study had an observational design, and the authors noted that residual confounding by diet, physical activity, and socioeconomic factors could not be completely ruled out.\", \"source_context\": {\"source_type\": \"Prospective observational study\", \"source_title_or_product_name\": \"Cohort study of coffee intake and risk of incident type 2 diabetes\", \"publication_year_or_version\": \", 2024\", \"study_design\": \"Prospective cohort study; groups were based on self-reported coffee intake at baseline, followed for 10 years, and adjusted hazard ratios were used to compare the risk of incident type 2 diabetes.\", \"population_description\": \"12,000 adults aged 30 to 65 without diabetes at baseline; the study population did not include children, older adults, or those with diabetes at baseline.\", \"intervention_description\": \"Observed participants' usual black coffee intake; the high-intake group self-reported drinking 3 or more cups per day, and coffee drinking was not randomly assigned.\", \"outcome_description\": \"Incident type 2 diabetes during follow-up, determined from medical records and study follow-up reports.\", \"study_conditions\": \"10-year observation period; coffee intake was mainly self-reported at baseline, and coffee type, cup size, brewing method, added sugar or milk, and other lifestyle factors were not strictly controlled.\"}}","{\"claim_category\": \"Disease risk\", \"claim_target\": \"Black coffee\", \"claimed_effect\": \"Reduces the risk of developing type 2 diabetes in adults by 30%\", \"claimed_effect_direction\": \"Lowers or reduces\", \"claimed_effect_strength\": \"Significant effect\", \"claimed_population\": \"Adults\", \"claimed_outcome\": \"Risk of developing type 2 diabetes\", \"claim_conditions\": \"Drinking three cups of black coffee per day; duration, cup size standards, or other lifestyle conditions not specified.\"}","{\"relation_label\": \"Partially supported\", \"support_level\": \"Medium\", \"dimension_assessment\": {\"effect_direction_match\": \"Complete match\", \"effect_strength_match\": \"Partial match\", \"population_match\": \"Partial match\", \"outcome_match\": \"Complete match\", \"condition_match\": \"Partial match\", \"evidence_design_relevance\": \"Partially relevant\"}, \"extrapolation_flags\": [\"Expanding the applicable population\", \"Ignoring study conditions\", \"Inferring causality from correlation\"], \"unsupported_claim_aspects\": [\"Has the same effect in all adults\", \"Drinking three cups of black coffee per day can causally reduce risk by 30%\", \"Effects are consistent across different coffee cup sizes, brewing methods, and lifestyles\"], \"is_overgeneralized\": true, \"support_score\": 0.48, \"confidence\": 0.92, \"reasoning\": \"The prospective cohort study reported an association between higher coffee intake and lower risk of incident type 2 diabetes; the outcome measure and direction are consistent with the advertisement, and the hazard ratio was about 0.70. However, the study did not randomly assign coffee intake, coffee amount was self-reported, and the population was limited to those aged 30 to 65 without diabetes at baseline; residual confounding cannot be ruled out. Therefore, the evidence only partially supports an association and cannot prove that drinking three cups of black coffee per day has a certain 30% causal risk reduction effect in all adults.\"}","{\"evidence_type\": \"Observational study\", \"evidence_population\": \"Adults aged 30 to 65 without diabetes at baseline, totaling 12,000 people.\", \"evidence_intervention\": \"Observed self-reported coffee intake; the high-intake group drank 3 or more cups per day; no randomized intervention was performed.\", \"evidence_outcome\": \"Incident type 2 diabetes during 10-year follow-up; the high-intake group had an adjusted hazard ratio of 0.70 relative to those drinking less than 1 cup per day.\", \"evidence_effect_direction\": \"Higher coffee intake was associated with a lower risk of incident type 2 diabetes.\", \"evidence_effect_strength\": \"An approximately 30% relative risk difference was observed, but this is an adjusted association estimate, and the causal effect size is uncertain.\", \"evidence_conditions\": \"Observed for 10 years; intake was mainly self-reported at baseline; cup size, brewing method, additives, diet, exercise, and other confounding factors were not strictly controlled.\", \"evidence_scope_summary\": \"The study supports an association between higher coffee intake and lower disease risk in a specific age group without diabetes at baseline, but it cannot by itself prove that drinking three cups of black coffee per day causally reduces risk by 30% in all adults.\"}",{"id":640,"relate_table":629,"relate_id":641,"file_size":572,"file_name":642,"path":8,"duration":572,"cate":483,"file_format":632,"audio_rate":8,"audio_channel":522,"audio_bit_depth":522,"quality":8,"annotation":643,"cate_name":634,"raw_material":644,"claim_annotation":645,"support_judgment":646,"evidence_annotation":647},14981,1774900822,"样例_2.json","{\"raw_material\": \"{\\\"ad_claim_text\\\": \\\"This high-concentration green tea catechin can kill cancer cells, and taking it at the recommended dosage can prevent colon cancer in everyone.\\\", \\\"citation_text\\\": \\\"Researchers observed the effect of green tea catechin extract on cell viability in cultured colon cancer cell lines.\\\", \\\"evidence_excerpt\\\": \\\"In two in vitro cultured colon cancer cell lines, after exposure to 20 to 50 micromolar green tea catechin for 24 hours, cell viability decreased by about 25% to 40% compared with the solvent control. The study did not use animals or human participants, nor did it assess whether oral products can achieve the same tissue concentration.\\\", \\\"source_context\\\": {\\\"source_type\\\": \\\"Mechanistic or laboratory study\\\", \\\"source_title_or_product_name\\\": \\\"In vitro experiment on the effect of green tea catechin on colon cancer cell viability\\\", \\\"publication_year_or_version\\\": \\\", 2022\\\", \\\"study_design\\\": \\\"In vitro cell culture experiment; different catechin concentrations and a solvent control were set up, and cell viability was observed after 24 hours.\\\", \\\"population_description\\\": \\\"Two cultured colon cancer cell lines, not representative of animal or human populations.\\\", \\\"intervention_description\\\": \\\"Green tea catechin extract at 20 to 50 micromolar was added to the cell culture medium and exposed for 24 hours.\\\", \\\"outcome_description\\\": \\\"Change in colon cancer cell viability relative to the solvent control; cancer incidence, tumor shrinkage, or patient survival were not measured.\\\", \\\"study_conditions\\\": \\\"In vitro culture environment; catechin directly contacted cells for 24 hours; absorption, metabolism, tissue concentration, or safe human doses were not evaluated.\\\"}}\", \"claim_annotation\": \"{\\\"claim_category\\\": \\\"Disease risk\\\", \\\"claim_target\\\": \\\"High-concentration green tea catechin extract\\\", \\\"claimed_effect\\\": \\\"Kills cancer cells and prevents colon cancer in everyone\\\", \\\"claimed_effect_direction\\\": \\\"Prevention\\\", \\\"claimed_effect_strength\\\": \\\"Strong or nearly certain\\\", \\\"claimed_population\\\": \\\"Everyone\\\", \\\"claimed_outcome\\\": \\\"Colon cancer incidence and cancer cell elimination\\\", \\\"claim_conditions\\\": \\\"Oral use at the product's recommended dosage; specific dose or duration not stated.\\\"}\", \"support_judgment\": \"{\\\"relation_label\\\": \\\"Not supported\\\", \\\"support_level\\\": \\\"None\\\", \\\"dimension_assessment\\\": {\\\"effect_direction_match\\\": \\\"No match\\\", \\\"effect_strength_match\\\": \\\"No match\\\", \\\"population_match\\\": \\\"No match\\\", \\\"outcome_match\\\": \\\"No match\\\", \\\"condition_match\\\": \\\"No match\\\", \\\"evidence_design_relevance\\\": \\\"Not relevant\\\"}, \\\"extrapolation_flags\\\": [\\\"Expanding the applicable population\\\", \\\"Exaggerating effect strength\\\", \\\"Expanding outcome measures\\\", \\\"Ignoring dose or duration\\\", \\\"Inferring clinical effects from mechanistic evidence\\\"], \\\"unsupported_claim_aspects\\\": [\\\"Can prevent colon cancer in everyone\\\", \\\"Oral products can achieve experimental concentrations in the human body\\\", \\\"Can kill cancer cells in the human body or improve patient outcomes\\\", \\\"Certain effects can be obtained at the recommended dosage\\\"], \\\"is_overgeneralized\\\": true, \\\"support_score\\\": 0.03, \\\"confidence\\\": 0.99, \\\"reasoning\\\": \\\"This evidence is an in vitro cell experiment; what was observed was reduced cancer cell viability after direct exposure to specific high concentrations of catechin. It did not study human absorption, actual tissue concentrations, cancer incidence, or patient treatment outcomes. The advertisement directly converts laboratory mechanistic findings into cancer prevention and certain therapeutic effects for everyone, and it does not provide comparable oral dosage and duration, so it does not support the advertising claim.\\\"}\", \"evidence_annotation\": \"{\\\"evidence_type\\\": \\\"Mechanistic or laboratory study\\\", \\\"evidence_population\\\": \\\"Two in vitro cultured colon cancer cell lines; does not include animal or human participants.\\\", \\\"evidence_intervention\\\": \\\"Green tea catechin extract at 20 to 50 micromolar was added directly to the cell culture medium and exposed for 24 hours.\\\", \\\"evidence_outcome\\\": \\\"Colon cancer cell viability decreased by about 25% to 40%; there were no clinical indicators of cancer prevention or treatment.\\\", \\\"evidence_effect_direction\\\": \\\"In vitro cell viability decreased, but this cannot be used to infer a decreased risk of colon cancer in humans.\\\", \\\"evidence_effect_strength\\\": \\\"Moderate inhibition of cell viability occurred under specific in vitro concentrations and 24-hour conditions; human effects and certainty are unknown.\\\", \\\"evidence_conditions\\\": \\\"Limited to in vitro culture, specific concentrations, and 24-hour exposure; no information on oral absorption, in vivo concentration, dosage safety, or clinical follow-up.\\\", \\\"evidence_scope_summary\\\": \\\"The evidence only shows that green tea catechin may affect colon cancer cell viability in vitro; it cannot cover human colon cancer prevention, treatment effects, applicable populations, or oral product dosage.\\\"}\"}","{\"ad_claim_text\": \"This high-concentration green tea catechin can kill cancer cells, and taking it at the recommended dosage can prevent colon cancer in everyone.\", \"citation_text\": \"Researchers observed the effect of green tea catechin extract on cell viability in cultured colon cancer cell lines.\", \"evidence_excerpt\": \"In two in vitro cultured colon cancer cell lines, after exposure to 20 to 50 micromolar green tea catechin for 24 hours, cell viability decreased by about 25% to 40% compared with the solvent control. The study did not use animals or human participants, nor did it assess whether oral products can achieve the same tissue concentration.\", \"source_context\": {\"source_type\": \"Mechanistic or laboratory study\", \"source_title_or_product_name\": \"In vitro experiment on the effect of green tea catechin on colon cancer cell viability\", \"publication_year_or_version\": \", 2022\", \"study_design\": \"In vitro cell culture experiment; different catechin concentrations and a solvent control were set up, and cell viability was observed after 24 hours.\", \"population_description\": \"Two cultured colon cancer cell lines, not representative of animal or human populations.\", \"intervention_description\": \"Green tea catechin extract at 20 to 50 micromolar was added to the cell culture medium and exposed for 24 hours.\", \"outcome_description\": \"Change in colon cancer cell viability relative to the solvent control; cancer incidence, tumor shrinkage, or patient survival were not measured.\", \"study_conditions\": \"In vitro culture environment; catechin directly contacted cells for 24 hours; absorption, metabolism, tissue concentration, or safe human doses were not evaluated.\"}}","{\"claim_category\": \"Disease risk\", \"claim_target\": \"High-concentration green tea catechin extract\", \"claimed_effect\": \"Kills cancer cells and prevents colon cancer in everyone\", \"claimed_effect_direction\": \"Prevention\", \"claimed_effect_strength\": \"Strong or nearly certain\", \"claimed_population\": \"Everyone\", \"claimed_outcome\": \"Colon cancer incidence and cancer cell elimination\", \"claim_conditions\": \"Oral use at the product's recommended dosage; specific dose or duration not stated.\"}","{\"relation_label\": \"Not supported\", \"support_level\": \"None\", \"dimension_assessment\": {\"effect_direction_match\": \"No match\", \"effect_strength_match\": \"No match\", \"population_match\": \"No match\", \"outcome_match\": \"No match\", \"condition_match\": \"No match\", \"evidence_design_relevance\": \"Not relevant\"}, \"extrapolation_flags\": [\"Expanding the applicable population\", \"Exaggerating effect strength\", \"Expanding outcome measures\", \"Ignoring dose or duration\", \"Inferring clinical effects from mechanistic evidence\"], \"unsupported_claim_aspects\": [\"Can prevent colon cancer in everyone\", \"Oral products can achieve experimental concentrations in the human body\", \"Can kill cancer cells in the human body or improve patient outcomes\", \"Certain effects can be obtained at the recommended dosage\"], \"is_overgeneralized\": true, \"support_score\": 0.03, \"confidence\": 0.99, \"reasoning\": \"This evidence is an in vitro cell experiment; what was observed was reduced cancer cell viability after direct exposure to specific high concentrations of catechin. It did not study human absorption, actual tissue concentrations, cancer incidence, or patient treatment outcomes. The advertisement directly converts laboratory mechanistic findings into cancer prevention and certain therapeutic effects for everyone, and it does not provide comparable oral dosage and duration, so it does not support the advertising claim.\"}","{\"evidence_type\": \"Mechanistic or laboratory study\", \"evidence_population\": \"Two in vitro cultured colon cancer cell lines; does not include animal or human participants.\", \"evidence_intervention\": \"Green tea catechin extract at 20 to 50 micromolar was added directly to the cell culture medium and exposed for 24 hours.\", \"evidence_outcome\": \"Colon cancer cell viability decreased by about 25% to 40%; there were no clinical indicators of cancer prevention or treatment.\", \"evidence_effect_direction\": \"In vitro cell viability decreased, but this cannot be used to infer a decreased risk of colon cancer in humans.\", \"evidence_effect_strength\": \"Moderate inhibition of cell viability occurred under specific in vitro concentrations and 24-hour conditions; human effects and certainty are unknown.\", \"evidence_conditions\": \"Limited to in vitro culture, specific concentrations, and 24-hour exposure; no information on oral absorption, in vivo concentration, dosage safety, or clinical follow-up.\", \"evidence_scope_summary\": \"The evidence only shows that green tea catechin may affect colon cancer cell viability in vitro; it cannot cover human colon cancer prevention, treatment effects, applicable populations, or oral product dosage.\"}",{"id":649,"relate_table":629,"relate_id":650,"file_size":572,"file_name":651,"path":8,"duration":572,"cate":483,"file_format":632,"audio_rate":8,"audio_channel":522,"audio_bit_depth":522,"quality":8,"annotation":652,"cate_name":634,"raw_material":653,"claim_annotation":654,"support_judgment":655,"evidence_annotation":656},14980,738608416,"样例_1.json","{\"raw_material\": \"{\\\"ad_claim_text\\\": \\\"Daily supplementation with 3 grams of oat beta-glucan for 8 consecutive weeks can significantly lower cholesterol and protect the heart health of all adults.\\\", \\\"citation_text\\\": \\\"An 8-week randomized, double-blind, placebo-controlled trial evaluated the effect of 3 grams per day of oat beta-glucan on blood lipids.\\\", \\\"evidence_excerpt\\\": \\\"In 120 adults aged 40 to 65 with mildly elevated LDL cholesterol, the beta-glucan group consumed 3 grams daily, and after 8 weeks LDL cholesterol decreased by an average of 6%; the placebo group decreased by 2%, and the between-group difference was statistically significant. The study did not measure cardiovascular events or long-term cardiac outcomes.\\\", \\\"source_context\\\": {\\\"source_type\\\": \\\"Randomized controlled clinical study\\\", \\\"source_title_or_product_name\\\": \\\"Randomized controlled trial of oat beta-glucan and changes in blood lipids\\\", \\\"publication_year_or_version\\\": \\\", 2023\\\", \\\"study_design\\\": \\\"Randomized, double-blind, placebo-controlled, parallel-group trial, 8-week intervention period.\\\", \\\"population_description\\\": \\\"120 adults aged 40 to 65 with mildly elevated LDL cholesterol; individuals with diagnosed cardiovascular disease were excluded.\\\", \\\"intervention_description\\\": \\\"The intervention group consumed 3 grams of oat beta-glucan powder daily, and the placebo group consumed an equal amount of inactive powder.\\\", \\\"outcome_description\\\": \\\"The primary outcome was change in LDL cholesterol; myocardial infarction, stroke, or other clinical cardiovascular events were not measured.\\\", \\\"study_conditions\\\": \\\"Once daily for 8 consecutive weeks; participants maintained their usual diet and activity habits; results were compared with the placebo group.\\\"}}\", \"claim_annotation\": \"{\\\"claim_category\\\": \\\"Body metric\\\", \\\"claim_target\\\": \\\"Oat beta-glucan\\\", \\\"claimed_effect\\\": \\\"Lowers cholesterol and protects heart health\\\", \\\"claimed_effect_direction\\\": \\\"Lowers or reduces\\\", \\\"claimed_effect_strength\\\": \\\"Significant effect\\\", \\\"claimed_population\\\": \\\"All adults\\\", \\\"claimed_outcome\\\": \\\"LDL cholesterol and heart health\\\", \\\"claim_conditions\\\": \\\"Daily supplementation with 3 grams for 8 consecutive weeks.\\\"}\", \"support_judgment\": \"{\\\"relation_label\\\": \\\"Partially supported\\\", \\\"support_level\\\": \\\"Medium\\\", \\\"dimension_assessment\\\": {\\\"effect_direction_match\\\": \\\"Partial match\\\", \\\"effect_strength_match\\\": \\\"Partial match\\\", \\\"population_match\\\": \\\"Partial match\\\", \\\"outcome_match\\\": \\\"Partial match\\\", \\\"condition_match\\\": \\\"Complete match\\\", \\\"evidence_design_relevance\\\": \\\"Partially relevant\\\"}, \\\"extrapolation_flags\\\": [\\\"Expanding the applicable population\\\", \\\"Exaggerating effect strength\\\", \\\"Expanding outcome measures\\\"], \\\"unsupported_claim_aspects\\\": [\\\"Applies to all adults\\\", \\\"Can protect heart health or reduce cardiovascular events\\\", \\\"Significant or strong long-term effects\\\"], \\\"is_overgeneralized\\\": true, \\\"support_score\\\": 0.62, \\\"confidence\\\": 0.94, \\\"reasoning\\\": \\\"The randomized controlled trial supports short-term reduction of LDL cholesterol with 3 grams per day of oat beta-glucan in specific adults with dyslipidemia, so the advertisement has some basis for the direction of cholesterol lowering and the usage conditions. However, the study lasted only 8 weeks, the effect size was small, and it did not measure cardiac protection or cardiovascular events, nor did it cover all adults. The advertisement expands a short-term change in a blood lipid marker into a general and significant cardiac protection conclusion, which is partially supported and involves overextrapolation.\\\"}\", \"evidence_annotation\": \"{\\\"evidence_type\\\": \\\"Randomized controlled trial\\\", \\\"evidence_population\\\": \\\"Adults aged 40 to 65 with mildly elevated LDL cholesterol and no diagnosed cardiovascular disease.\\\", \\\"evidence_intervention\\\": \\\"3 grams per day of oat beta-glucan for 8 consecutive weeks, compared with placebo.\\\", \\\"evidence_outcome\\\": \\\"LDL cholesterol decreased by an average of 6%, and the placebo group decreased by 2%; no cardiovascular events were reported.\\\", \\\"evidence_effect_direction\\\": \\\"LDL cholesterol decreased, consistent in direction with the part of the advertisement about lowering cholesterol.\\\", \\\"evidence_effect_strength\\\": \\\"Short-term mild to moderate reduction; the between-group difference was statistically significant, but a strong effect or clinical cardiac protection was not demonstrated.\\\", \\\"evidence_conditions\\\": \\\"Only in adults of a specific age with mild dyslipidemia, at 3 grams daily for 8 weeks; there was a placebo control, but long-term clinical outcomes were not evaluated.\\\", \\\"evidence_scope_summary\\\": \\\"The evidence supports a small short-term reduction in LDL cholesterol over 8 weeks in specific adults, but it does not cover all adults and does not support conclusions about reducing cardiovascular events such as myocardial infarction or stroke.\\\"}\"}","{\"ad_claim_text\": \"Daily supplementation with 3 grams of oat beta-glucan for 8 consecutive weeks can significantly lower cholesterol and protect the heart health of all adults.\", \"citation_text\": \"An 8-week randomized, double-blind, placebo-controlled trial evaluated the effect of 3 grams per day of oat beta-glucan on blood lipids.\", \"evidence_excerpt\": \"In 120 adults aged 40 to 65 with mildly elevated LDL cholesterol, the beta-glucan group consumed 3 grams daily, and after 8 weeks LDL cholesterol decreased by an average of 6%; the placebo group decreased by 2%, and the between-group difference was statistically significant. The study did not measure cardiovascular events or long-term cardiac outcomes.\", \"source_context\": {\"source_type\": \"Randomized controlled clinical study\", \"source_title_or_product_name\": \"Randomized controlled trial of oat beta-glucan and changes in blood lipids\", \"publication_year_or_version\": \", 2023\", \"study_design\": \"Randomized, double-blind, placebo-controlled, parallel-group trial, 8-week intervention period.\", \"population_description\": \"120 adults aged 40 to 65 with mildly elevated LDL cholesterol; individuals with diagnosed cardiovascular disease were excluded.\", \"intervention_description\": \"The intervention group consumed 3 grams of oat beta-glucan powder daily, and the placebo group consumed an equal amount of inactive powder.\", \"outcome_description\": \"The primary outcome was change in LDL cholesterol; myocardial infarction, stroke, or other clinical cardiovascular events were not measured.\", \"study_conditions\": \"Once daily for 8 consecutive weeks; participants maintained their usual diet and activity habits; results were compared with the placebo group.\"}}","{\"claim_category\": \"Body metric\", \"claim_target\": \"Oat beta-glucan\", \"claimed_effect\": \"Lowers cholesterol and protects heart health\", \"claimed_effect_direction\": \"Lowers or reduces\", \"claimed_effect_strength\": \"Significant effect\", \"claimed_population\": \"All adults\", \"claimed_outcome\": \"LDL cholesterol and heart health\", \"claim_conditions\": \"Daily supplementation with 3 grams for 8 consecutive weeks.\"}","{\"relation_label\": \"Partially supported\", \"support_level\": \"Medium\", \"dimension_assessment\": {\"effect_direction_match\": \"Partial match\", \"effect_strength_match\": \"Partial match\", \"population_match\": \"Partial match\", \"outcome_match\": \"Partial match\", \"condition_match\": \"Complete match\", \"evidence_design_relevance\": \"Partially relevant\"}, \"extrapolation_flags\": [\"Expanding the applicable population\", \"Exaggerating effect strength\", \"Expanding outcome measures\"], \"unsupported_claim_aspects\": [\"Applies to all adults\", \"Can protect heart health or reduce cardiovascular events\", \"Significant or strong long-term effects\"], \"is_overgeneralized\": true, \"support_score\": 0.62, \"confidence\": 0.94, \"reasoning\": \"The randomized controlled trial supports short-term reduction of LDL cholesterol with 3 grams per day of oat beta-glucan in specific adults with dyslipidemia, so the advertisement has some basis for the direction of cholesterol lowering and the usage conditions. However, the study lasted only 8 weeks, the effect size was small, and it did not measure cardiac protection or cardiovascular events, nor did it cover all adults. The advertisement expands a short-term change in a blood lipid marker into a general and significant cardiac protection conclusion, which is partially supported and involves overextrapolation.\"}","{\"evidence_type\": \"Randomized controlled trial\", \"evidence_population\": \"Adults aged 40 to 65 with mildly elevated LDL cholesterol and no diagnosed cardiovascular disease.\", \"evidence_intervention\": \"3 grams per day of oat beta-glucan for 8 consecutive weeks, compared with placebo.\", \"evidence_outcome\": \"LDL cholesterol decreased by an average of 6%, and the placebo group decreased by 2%; no cardiovascular events were reported.\", \"evidence_effect_direction\": \"LDL cholesterol decreased, consistent in direction with the part of the advertisement about lowering cholesterol.\", \"evidence_effect_strength\": \"Short-term mild to moderate reduction; the between-group difference was statistically significant, but a strong effect or clinical cardiac protection was not demonstrated.\", \"evidence_conditions\": \"Only in adults of a specific age with mild dyslipidemia, at 3 grams daily for 8 weeks; there was a placebo control, but long-term clinical outcomes were not evaluated.\", \"evidence_scope_summary\": \"The evidence supports a small short-term reduction in LDL cholesterol over 8 weeks in specific adults, but it does not cover all adults and does not support conclusions about reducing cardiovascular events such as myocardial infarction or stroke.\"}","{\"raw_material\":\"{\\\"ad_claim_text\\\": \\\"Drinking three cups of black coffee per day can reduce the risk of type 2 diabetes in adults by 30%.\\\", \\\"citation_text\\\": \\\"A prospective cohort study followed adults without diabetes and compared the relationship between different coffee intake levels and subsequent development of type 2 diabetes.\\\", \\\"evidence_excerpt\\\": \\\"The study included 12,000 adults aged 30 to 65 without diabetes at baseline and followed them for 10 years. Compared with those who drank less than 1 cup per day, self-reported drinkers of 3 or more cups of coffee per day had an adjusted hazard ratio of 0.70 for developing type 2 diabetes. The study had an observational design, and the authors noted that residual confounding by diet, physical activity, and socioeconomic factors could not be completely ruled out.\\\", \\\"source_context\\\": {\\\"source_type\\\": \\\"Prospective observational study\\\", \\\"source_title_or_product_name\\\": \\\"Cohort study of coffee intake and risk of incident type 2 diabetes\\\", \\\"publication_year_or_version\\\": \\\", 2024\\\", \\\"study_design\\\": \\\"Prospective cohort study; groups were based on self-reported coffee intake at baseline, followed for 10 years, and adjusted hazard ratios were used to compare the risk of incident type 2 diabetes.\\\", \\\"population_description\\\": \\\"12,000 adults aged 30 to 65 without diabetes at baseline; the study population did not include children, older adults, or those with diabetes at baseline.\\\", \\\"intervention_description\\\": \\\"Observed participants' usual black coffee intake; the high-intake group self-reported drinking 3 or more cups per day, and coffee drinking was not randomly assigned.\\\", \\\"outcome_description\\\": \\\"Incident type 2 diabetes during follow-up, determined from medical records and study follow-up reports.\\\", \\\"study_conditions\\\": \\\"10-year observation period; coffee intake was mainly self-reported at baseline, and coffee type, cup size, brewing method, added sugar or milk, and other lifestyle factors were not strictly controlled.\\\"}}\",\"claim_annotation\":\"{\\\"claim_category\\\": \\\"Disease risk\\\", \\\"claim_target\\\": \\\"Black coffee\\\", \\\"claimed_effect\\\": \\\"Reduces the risk of developing type 2 diabetes in adults by 30%\\\", \\\"claimed_effect_direction\\\": \\\"Lowers or reduces\\\", \\\"claimed_effect_strength\\\": \\\"Significant effect\\\", \\\"claimed_population\\\": \\\"Adults\\\", \\\"claimed_outcome\\\": \\\"Risk of developing type 2 diabetes\\\", \\\"claim_conditions\\\": \\\"Drinking three cups of black coffee per day; duration, cup size standards, or other lifestyle conditions not specified.\\\"}\",\"support_judgment\":\"{\\\"relation_label\\\": \\\"Partially supported\\\", \\\"support_level\\\": \\\"Medium\\\", \\\"dimension_assessment\\\": {\\\"effect_direction_match\\\": \\\"Complete match\\\", \\\"effect_strength_match\\\": \\\"Partial match\\\", \\\"population_match\\\": \\\"Partial match\\\", \\\"outcome_match\\\": \\\"Complete match\\\", \\\"condition_match\\\": \\\"Partial match\\\", \\\"evidence_design_relevance\\\": \\\"Partially relevant\\\"}, \\\"extrapolation_flags\\\": [\\\"Expanding the applicable population\\\", \\\"Ignoring study conditions\\\", \\\"Inferring causality from correlation\\\"], \\\"unsupported_claim_aspects\\\": [\\\"Has the same effect in all adults\\\", \\\"Drinking three cups of black coffee per day can causally reduce risk by 30%\\\", \\\"Effects are consistent across different coffee cup sizes, brewing methods, and lifestyles\\\"], \\\"is_overgeneralized\\\": true, \\\"support_score\\\": 0.48, \\\"confidence\\\": 0.92, \\\"reasoning\\\": \\\"The prospective cohort study reported an association between higher coffee intake and lower risk of incident type 2 diabetes; the outcome measure and direction are consistent with the advertisement, and the hazard ratio was about 0.70. However, the study did not randomly assign coffee intake, coffee amount was self-reported, and the population was limited to those aged 30 to 65 without diabetes at baseline; residual confounding cannot be ruled out. Therefore, the evidence only partially supports an association and cannot prove that drinking three cups of black coffee per day has a certain 30% causal risk reduction effect in all adults.\\\"}\",\"evidence_annotation\":\"{\\\"evidence_type\\\": \\\"Observational study\\\", \\\"evidence_population\\\": \\\"Adults aged 30 to 65 without diabetes at baseline, totaling 12,000 people.\\\", \\\"evidence_intervention\\\": \\\"Observed self-reported coffee intake; the high-intake group drank 3 or more cups per day; no randomized intervention was performed.\\\", \\\"evidence_outcome\\\": \\\"Incident type 2 diabetes during 10-year follow-up; the high-intake group had an adjusted hazard ratio of 0.70 relative to those drinking less than 1 cup per day.\\\", \\\"evidence_effect_direction\\\": \\\"Higher coffee intake was associated with a lower risk of incident type 2 diabetes.\\\", \\\"evidence_effect_strength\\\": \\\"An approximately 30% relative risk difference was observed, but this is an adjusted association estimate, and the causal effect size is uncertain.\\\", \\\"evidence_conditions\\\": \\\"Observed for 10 years; intake was mainly self-reported at baseline; cup size, brewing method, additives, diet, exercise, and other confounding factors were not strictly controlled.\\\", \\\"evidence_scope_summary\\\": \\\"The study supports an association between higher coffee intake and lower disease risk in a specific age group without diabetes at baseline, but it cannot by itself prove that drinking three cups of black coffee per day causally reduces risk by 30% in all adults.\\\"}\"}","MOBIUSI INC","https:\u002F\u002Fstatic.mobiusi.com\u002Fmobiwusi\u002F20250829\u002F7bf4ac62b4533e2b809998a6f1c5491e.png?Expires=1792463130&OSSAccessKeyId=LTAI5tH8MQqhgeiAtrzCHrxM&Signature=v6Tr8jBrdm4s5wU1SnnyGsYg%2Bhw%3D&x-oss-process=image%2Fresize%2Cm_fill%2Cw_35%2Ch_35",[661,667],{"type":662,"title":663,"count_data":664},"bar","Length distribution",[665],{"name":666,"value":483},"1k lower",{"type":668,"title":669,"count_data":670},"pie","Language distribution",[671],{"name":672,"value":483},"English"]